Post COVID-19 Infection Psychosis: Could SARS-CoV-2 Virus Infection Be a Neuropsychiatric Condition That Triggers Psychotic Disorders? – A Case-Based Short Review

References

• Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552–555. doi:10.1002/jmv.25728
   PubMed Web of Science ®Google Scholar
• Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82:12. doi:10.1128/JVI.00737-08
   Web of Science ®Google Scholar
• Severance EG, Dickerson FB, Viscidi RP, et al. Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms. Schizophr Bull. 2011;37:101–107. doi:10.1093/schbul/sbp052
   PubMed Web of Science ®Google Scholar
• Steardo L, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol. 2020;229(3):e13473.
   PubMed Web of Science ®Google Scholar
• Yang P, Wang X. COVID-19: a new challenge for human beings. Cell Mol Immunol. 2020;17:555–557. doi:10.1038/s41423-020-0407-x
   PubMed Web of Science ®Google Scholar
• Ueda M, Nordström R, Matsubayashi T. Suicide and mental health during the COVID-19 pandemic in Japan. J Public Health. 2021;fdab113. doi:10.1093/pubmed/fdab113
   Web of Science ®Google Scholar
• Nicola M, Alsafi Z, Sohrabi C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg. 2020;78:185–193. doi:10.1016/j.ijsu.2020.04.018
   PubMed Web of Science ®Google Scholar
• Srivastava N, Saxena SK. Prevention and Control Strategies for SARS-CoV-2 Infection. Coronavirus Dis 2019. 2020;30:127–140.
   Google Scholar
• Vasile MC, Arbune AA, Lupasteanu G, Vlase CM, Popovici GC, Arbune M. Epidemiologic and clinic characteristics of the first wave of the COVID-19 pandemic in hospitalized patients from galați county. J Clin Med. 2021;10(18):4210. doi:10.3390/jcm10184210
   Web of Science ®Google Scholar
• Tatu AL, Nadasdy T, Bujoreanu FC. Familial clustering of COVID-19 skin manifestations. Dermatol Ther. 2020;33(6). doi:10.1111/dth.14181
   Web of Science ®Google Scholar
• Niculet E, Chioncel V, Elisei AM, et al. Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review). Exp Ther Med. 2021;21(3):263. doi:10.3892/etm.2021.9693
   PubMed Web of Science ®Google Scholar
• Tatu AL, Nadasdy T, Nwabudike LC. Observations about sexual and other routes of SARS-CoV-2 (COVID-19) transmission and its prevention. Clin Exp Dermatol. 2020;45(6):761–762. doi:10.1111/ced.14274
   PubMed Web of Science ®Google Scholar
• AlRasheed MM, Alkadir AM, Bin Shuqiran KI, Al-Aqeel S, Jahrami HA, BaHammam AS. The impact of quarantine on sleep quality and psychological distress during the COVID-19 pandemic. Nat Sci Sleep. 2021;13:1037–1048. doi:10.2147/NSS.S313373
   PubMed Web of Science ®Google Scholar
• Bueno-Notivol J, Gracia-García P, Olaya B, Lasheras I, López-Antón R, Santabárbara J. Prevalence of depression during the COVID-19 outbreak: a meta-analysis of community-based studies. Int J Clin Health Psychol. 2021;21(1):100196. doi:10.1016/j.ijchp.2020.07.007
   PubMed Web of Science ®Google Scholar
• van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39(2):179–195. doi:10.1017/S0033291708003814
   PubMed Web of Science ®Google Scholar
• Rentero D, Juanes A, Losada CP, et al. New-onset psychosis in COVID-19 pandemic: a case series in Madrid. Psychiatry Res. 2020;290:113097. doi:10.1016/j.psychres.2020.113097
   PubMed Web of Science ®Google Scholar
• Watson CJ, Thomas RH, Solomon T, Michael BD, Nicholson TR, Pollak TA. COVID-19 and psychosis risk: real or delusional concern? Neurosci Lett. 2021;741:135491. doi:10.1016/j.neulet.2020.135491
   PubMed Web of Science ®Google Scholar
• Smith CM, Gilbert EB, Riordan PA, et al. COVID-19-associated psychosis: a systematic review of case reports. Gen Hosp Psychiatry. 2021;73:84–100. doi:10.1016/j.genhosppsych.2021.10.003
   PubMed Web of Science ®Google Scholar
• Desforges M, Coupanec AL, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12:14. doi:10.3390/v12010014
   PubMed Web of Science ®Google Scholar
• Sheng B, Cheng SKW, Lau KK, Li HL, Chan ELY. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2005;20:236–242. doi:10.1016/j.eurpsy.2004.06.023
   PubMed Web of Science ®Google Scholar
• Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci. 2009;106:14063–14068. doi:10.1073/pnas.0900096106
   PubMed Web of Science ®Google Scholar
• Li X, Okada T, Kodera M, et al. Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease. Mol Ther. 2006;13:160–166. doi:10.1016/j.ymthe.2005.08.009
   PubMed Web of Science ®Google Scholar
• Kannan G, Gressitt KL, Yang S, et al. Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Transl Psychiatry. 2017;7:e1186. doi:10.1038/tp.2017.162
   Web of Science ®Google Scholar
• Kępinska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and influenza at the centenary of the 1918–1919 Spanish influenza pandemic: mechanisms of psychosis risk. Front Psychiatry. 2020;11:72. doi:10.3389/fpsyt.2020.00072
   PubMed Web of Science ®Google Scholar
• Kulaga SS, Miller CWT. Viral respiratory infections and psychosis: a review of the literature and the implications of COVID-19. Neurosci Biobehav Rev. 2021;127:520–530. doi:10.1016/j.neubiorev.2021.05.008
   PubMed Web of Science ®Google Scholar
• Cheng SK-W, Tsang JS-K, Ku K-H, Wong C-W, Ng Y-K. Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: a series of 10 cases. Br J Psychiatry. 2004;184:359–360. doi:10.1192/bjp.184.4.359
   PubMed Web of Science ®Google Scholar
• Lee DTS, Wing YK, Leung HCM, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis. 2004;39:1247–1249. doi:10.1086/424016
   Web of Science ®Google Scholar
• Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between covid-19 and psychiatric disorder. Lancet Psychiatry. 2020;8(2):130–140. doi:10.1016/S2215-0366(20)30462-4
   PubMed Web of Science ®Google Scholar
• Wang C, Pan R, Wan X, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020;7:40–48. doi:10.1016/j.bbi.2020.04.028
   Web of Science ®Google Scholar
• Jones AE, Trzeciak S, Kline JA. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37:1649–1650. doi:10.1097/CCM.0b013e31819def97
   PubMed Web of Science ®Google Scholar
• Horby P, Lim WS, Emberson JR, et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704.
   PubMed Web of Science ®Google Scholar
• Saoud A-B, Salim A-H, Ruqaiya A-S, Zishan AA, Moghadas M, Al-Adawi S. COVID-19 induced new-onset psychosis: a case report from Oman. Oman Med J. 2021;36(5):e303. doi:10.5001/omj.2022.25
   Google Scholar
• Zulkifli NA, Sivapatham S, Guan NC. Brief psychotic disorder in relation to coronavirus COVID-19 outbreaks: a case report. Malay J Psychiatry. 2020;29:1–6.
   Google Scholar
• López-Díaz Á, Lorenzo-Herrero P, Lara I, Fernández-González JL, Ruiz-Veguilla M. Acute stress and substance use as predictors of suicidal behaviour in acute and transient psychotic disorders. Psychiatry Res. 2018;269:414–418. doi:10.1016/j.psychres.2018.08.036
   Web of Science ®Google Scholar
• Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–627. doi:10.1016/S2215-0366(20)30203-0
   PubMed Web of Science ®Google Scholar
• Moryś JM, Jeżewska M, Korzeniewski K. Neuropsychiatric manifestations of some tropical diseases. Int Marit Health. 2015;66(1):30–35. doi:10.5603/IMH.2015.0009
   Google Scholar
• Gorska AM, Eugenin EA. The glutamate system as a crucial regulator of CNS toxicity and survival of HIV reservoirs.. Front Cell Infect Microbiol. 2020;10:261. doi:10.3389/fcimb.2020.00261
   Web of Science ®Google Scholar
• Essali N, Miller BJ. Psychosis as an adverse effect of antibiotics. Brain Behavior Immunity Health. 2020;9:100148.
   Google Scholar
• Telles-Garcia N, Zahrli T, Aggarwal G, Bansal S, Richards L, Aggarwal S. Suicide attempt as the presenting symptom in a patient with COVID-19: a case report from the United States. Case Rep Psychiatry. 2020;2020:1–3. doi:10.1155/2020/8897454
   Google Scholar
• Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179–2184. doi:10.1007/s00415-020-09929-7
   PubMed Web of Science ®Google Scholar
• Smith CM, Komisar JR, Mourad A, Kincaid BR. COVID-19-associated brief psychotic disorder. BMJ Case Rep. 2020;13(8):236940. doi:10.1136/bcr-2020-236940
   PubMedGoogle Scholar
• Fierini F, Moretti D, Ballerini A. Psychosis spectrum disorders during and after the COVID-19 pandemic: warning signs of “stress incubation”. Psychiatry Res. 2020;291:113291. doi:10.1016/j.psychres.2020.113291
   Web of Science ®Google Scholar
• Castagnini AC, Galeazzi GM. Acute and transient psychoses: clinical and nosological issues. BJPsych Adv. 2016;22:292–300. doi:10.1192/apt.bp.115.015198
   Google Scholar
• Castagnini AC, Fusar-Poli P. Diagnostic validity of ICD-10 acute and transient psychotic disorders and DSM-5 brief psychotic disorder. Eur Psychiatry. 2017;45:104–113. doi:10.1016/j.eurpsy.2017.05.028
   PubMed Web of Science ®Google Scholar
• Wang HY, Guo WJ, Li XJ, et al. Higher required dosage of antipsychotics to relieve the symptoms of first-onset Acute and Transient Psychotic Disorder (ATPD) predicted the subsequent diagnostic transition to schizophrenia: a longitudinal study. Schizophr Res. 2018;193:461–462. doi:10.1016/j.schres.2017.07.011
   Web of Science ®Google Scholar
• Ciobotaru OR, Lupu MN, Rebegea L, et al. Dexamethasone-chemical structure and mechanisms of action in prophylaxis of postoperative side effects. Rev Chim. 2019;70(3):843–847. doi:10.37358/RC.19.3.7017
   Web of Science ®Google Scholar
• Queirazza F, Semple DM, Lawrie SM. Transition to schizophrenia in acute and transient psychotic disorders. Br J Psychiatry. 2014;204:299–305. doi:10.1192/bjp.bp.113.127340
   PubMed Web of Science ®Google Scholar
• Mitjà O, Arenas À, Rodó X, Tobias A, Brew J, Benlloch JM. Experts’ request to the Spanish Government: move Spain towards complete lockdown. Lancet. 2020;395(10231):1193–1194. doi:10.1016/S0140-6736(20)30753-4
   PubMed Web of Science ®Google Scholar
• Beards S, Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C. Life events and psychosis: a review and metaanalysis. Schizophr Bull. 2013;39:740–747. doi:10.1093/schbul/sbt065
   PubMed Web of Science ®Google Scholar
• Taylor SF, Grove TB, Ellingrod VL, Tso IF. The fragile brain: stress vulnerability, negative affect and gabaergic neurocircuits in psychosis. Schizophr Bull. 2019;45:1170–1183. doi:10.1093/schbul/sbz046
   PubMed Web of Science ®Google Scholar
• Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull. 2018;44:973–982. doi:10.1093/schbul/sby024
   PubMed Web of Science ®Google Scholar
• Hong J, Bang M. Anti-inflammatory strategies for schizophrenia: a review of evidence for therapeutic applications and drug repurposing. Clin Psychopharmacol Neurosci. 2020;18:10–24. doi:10.9758/cpn.2020.18.1.10
   Web of Science ®Google Scholar